Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Hello Everyone.
View:
Post by account15 on Nov 18, 2015 12:45pm

Hello Everyone.

Just join in to that online meeting. Anyone listened from the beginning? Anything of concern was said to drive stock price. Thanks GlaGla
Comment by loveshackdave on Nov 18, 2015 12:52pm
AdComm panel epxressed concerns about DFS rate calculations which is the main reason the SP dropped IMO. They have also expressed concerns about safety and efficacay compared with cystectomy but I think those concerns were expertly addressed by Telesta. The major sticking point for the panel is the incomplete data. My gut is telling me that they will recommend another PIII. They may recommend this ...more  
Comment by investderp on Nov 18, 2015 12:56pm
Seems pretty stupid considering the FDA's presentation is their briefing document which was posted Monday. Apparently nobody read it?
Comment by loveshackdave on Nov 18, 2015 1:03pm
The majority of the drop was on low volume so that may be part of it. The other part is that the actual data and the AdCom's response to the data are entirely different things. The latter was not known until this morning.
Comment by investderp on Nov 18, 2015 1:07pm
I disagree; the AdCom didn't start asking questions until after the drop, the FDA were still going over their briefing material presentation.
Comment by frnwid on Nov 18, 2015 1:09pm
Agreed.  Someone cashed out BEFORE and it triggered a pile of stop losses and some panic as a result.  Don't forget some people have made a pretty penny in short order, they're traders not investors, take the profit and run.  As for the questions, they aren't there to pat us on the back about our great drug, they're there to put us through our paces.  I'm ...more  
Comment by DamnYankees on Nov 18, 2015 1:19pm
I think that retailers got gamed today  for a sizeable chunk of these shares. If they were expecting a love in they miscalculated badly.
Comment by ragingbull1327 on Nov 18, 2015 12:57pm
The panel sees a problem with the data?    Yet the same group approved a placebo.    Awesome
Comment by investderp on Nov 18, 2015 12:58pm
What are you smoking?  What placebo?
Comment by ragingbull1327 on Nov 18, 2015 1:38pm
Way placebo??   Sorry you're right it's WORSE than a placebo.   It's only 10% effective and its chemo based.     It sucks
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities